being and becoming in the world
The Minutes of the Psychopharmacology Committee of the Royal College of Psychiatrists provide some insight into high-level decision making on the education of psychiatrists and their approach to prescribing. The … Continue reading “Dominated by people against psychiatric medication”
In February 2015 I wrote to my College and the General Medical Council about concerns that competing financial interests were not being made public and that the current College system … Continue reading “We have an appropriately puritanical relationship with Pharma”
Professor David Baldwin took chairmanship of the Royal College of Psychiatrists Psychopharmacology Committee when Professor Allan Young had completed his tenure as chair. Based on available evidence, and this is … Continue reading The Psychopharmacology Committee [Chaired by Paid Opinion Leaders]
A few days ago I received this e-mail, marked “High importance” from the “HR Department” of the Royal College of Psychiatrists which has left me upset: This was the e-mail that … Continue reading Let us be kind to one another even when views may differ
In an NHS e-mail with a wide distribution list, I was invited to this marketing event. Though it is titled “Current updates in treatment for schizophrenia” the following programme demonstrates … Continue reading Marketing of Latuda in NHS Scotland
On the 25th February 2018 the following letter was published in the Times. It was written by Professor David Baldwin, Chair of the Psychopharmacology Committee, and Professor Wendy Burn, the … Continue reading A letter in the Times: ‘Pills for depression’
This leter has been published in the current edition of The BMJ: Reading this letter my thoughts returned to a lecture given by Professor Allan Young at a Royal College … Continue reading “A huge number of ‘bipolars’ are missed”